← Open Payments lookup

JESSICA BRZOZOWSKI: Open Payments

NPI 1982941266 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,102 in 83 payments from 15 companies in 2025. Trend: 2023 $2,402 · 2024 $1,962 · 2025 $2,102

Food & beverage: $2,102
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc8$376
ABBVIE INC.13$330
Otsuka America Pharmaceutical, Inc.14$283
Alkermes, Inc.16$281
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$198
Supernus Pharmaceuticals, Inc.6$192
Lundbeck LLC4$99
Vertical Pharmaceuticals, LLC5$91
Axsome Therapeutics, Inc.3$86
Takeda Pharmaceuticals U.S.A., Inc.3$62

Products named: SPRAVATO, REXULTI, VRAYLAR, ARISTADA, CAPLYTA, Qelbree, Relexxii, Auvelity.

Industry payments across TX — which companies pay providers there.